Scientists test new HIV vaccine strategy in healthy volunteers
NCT ID NCT03220724
Summary
This study tested the safety and immune response of several experimental HIV vaccines in healthy adults who do not have HIV. The main goal was to see if the vaccine shots were safe and if they could trigger the body to produce antibodies that might fight the virus. Researchers enrolled 117 participants and gave them a series of injections over several months to monitor for side effects and measure immune responses.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIV INFECTIONS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Alabama CRS
Birmingham, Alabama, 35294, United States
-
Bridge HIV CRS
San Francisco, California, 94102, United States
-
Brigham and Women's Hospital Vaccine CRS (BWH VCRS)
Boston, Massachusetts, 02115-6110, United States
-
Columbia P&S CRS
New York, New York, 10032-3732, United States
-
New York Blood Center CRS
New York, New York, 10065, United States
-
Penn Prevention CRS
Philadelphia, Pennsylvania, 19104, United States
-
Seattle Vaccine and Prevention CRS
Seattle, Washington, 98104, United States
-
University of Rochester Vaccines to Prevent HIV Infection CRS
Rochester, New York, 14642, United States
Conditions
Explore the condition pages connected to this study.